Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Bipolar Disorder

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lorazepam use during clinical trials of adults with bipolar mania episodes.

Contemporary clinical trials communications·2023

Same author

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary.

Frontiers in psychiatry·2021

Same author

A Critique on Psychiatric Inpatient Admissions for Suicidality in Youth.

The Journal of nervous and mental disease·2021

Same author

Antidepressant Use in Medicaid-Insured Youth: Trends, Covariates, and Future Research Needs.

Frontiers in psychiatry·2020

Same author

Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns.

Frontiers in psychiatry·2019

Same author

Overprescribed Medications for US Adults: Four Major Examples.

Journal of clinical medicine research·2019

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Mood swing and mood stabilizer: how specific are these terms?

Daniel J Safer¹

¹Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. dsafer@jhmi.edu

Bipolar Disorders

|November 3, 2010

Summary

Psychiatric terms like "mood swing" and "mood stabilizer" are often misleading and lack clear definitions. Further research is needed to understand mood variations and improve treatment decisions for mood disorders.

More Related Videos

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Related Experiment Videos

Last Updated: Jun 7, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

Psychiatry
Mental Health

Background:

The classification of mood disorders evolved, with
affective disorders
renamed
mood disorders
in 1987.
The terms
mood swing
and
mood stabilizer
gained widespread use in psychiatry shortly after this change.

Purpose of the Study:

To review the definitions and usage of terms related to mood fluctuations in psychiatric literature.
To assess the clarity and clinical utility of terms like
mood swing
and
mood stabilizer
.

Main Methods:

A review of recent texts, articles, and dictionaries.
Analysis of the terminology used to describe mood fluctuations in psychiatric contexts.

Main Results:

The term
mood
was rarely used in psychiatric terminology before the late 1970s.
"Mood swing" and "mood stabilizer" are often nonspecific and potentially misleading in psychiatric literature, impacting treatment decisions.
The perception of affective fluctuations in personality and depressive disorders as cyclically biphasic (depressed to elated) contradicts research findings.

Conclusions:

Current terminology regarding mood variations is often imprecise and can be misleading.
There is a need for more data-driven research into mood variations to establish clearer definitions and improve clinical practice.